Pulse Biosciences Stock Price - PLSE

7.02
0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Pulse Biosciences Inc PLSE NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.59 -7.75% 7.02 7.00 7.70 7.70 7.61 20:00:00
Bid Price Ask Price Spread Spread % News
6.63 8.68 2.05 23.62% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,004 137,898 $ 7.34 $ 1,011,667 83,688 6.81 - 19.77
Last Trade Time Type Quantity Stock Price Currency
16:41:06 7 $ 7.02 USD

Pulse Biosciences Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 145.93M 20.79M $ -37.55M -2.20 - 11.47M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 2.00 44.80%

more financials information »

Pulse Biosciences News

Loading Messages....

Latest PLSE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PLSE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.008.766.818.31456,0650.020.29%
1 Month14.4214.866.819.71128,023-7.40-51.32%
3 Months14.4016.2456.8111.6273,851-7.38-51.25%
6 Months11.4317.456.8112.9661,292-4.41-38.58%
1 Year16.6319.776.8113.5756,423-9.61-57.79%
3 Years14.1739.506.8120.16139,023-7.15-50.46%
5 Years4.1339.504.0319.28118,7662.8969.98%

Pulse Biosciences Description

Pulse Biosciences Inc is a United States based clinical stage medical therapy company which pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage.


Your Recent History
NASDAQ
PLSE
Pulse Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.